Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04142060
Title Targeting PAM50 Her2-Enriched Phenotype With Enzalutamide in Hormone Receptor-Positive/Her2-Negative Metastatic Breast Cancer (ARIANNA)
Acronym ARIANNA
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
ICO Badalona Badalona Barcelona Spain Details
Institut Català d'Oncologia Hospitalet Hospitalet de Llobregat Barcelona Spain Details
Hospital Clinic de Barcelona Barcelona Spain Details
Hospital Universitari Vall d' Hebrón Barcelona Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario Fundación de Alcorcón Madrid Spain Details
Hospital Universitario Virgen del Rocio Sevilla Spain Details
Fundación Instituto Valenciano de Oncología Valencia 46009 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field